Revitalizing aging muscles: harnessing NAD⁺, sirtuins, and exercise to combat sarcopenia

Russian Journal of Organic Chemistry · Springer Nature · 2026-11-03 · DOI: 10.1007/s10863-026-10140-y

Аннотация

Aging is associated with systemic metabolic dysfunction that contributes to geriatric syndromes such as sarcopenia—the progressive loss of skeletal muscle mass and function. Evidence from preclinical models suggests that age-associated depletion of nicotinamide adenine dinucleotide (NAD⁺) may contribute to this decline by limiting the activity of sirtuin deacetylases (SIRT1–7). These enzymes act as metabolic sensors regulating mitochondrial biogenesis, oxidative capacity, DNA repair and pathways related to muscle atrophy. Physical exercise enhances NAD⁺ salvage through upregulation of nicotinamide phosphoribosyltransferase (NAMPT). Pharmacological approaches including NAD⁺ precursor supplementation (nicotinamide riboside or nicotinamide mononucleotide) and inhibition of NAD⁺-consuming enzymes have shown benefits in preclinical models. However, clinical translation remains inconsistent. Recent meta-analyses have found no significant effect of these precursors on muscle mass or strength in adults aged over 60 years. Moreover, experimental evidence indicates that even profound NAD⁺ depletion in adult mouse skeletal muscle does not necessarily compromise function or accelerate aging. We conclude that pharmacological NAD⁺ restoration alone is currently insufficient to reverse sarcopenia in humans. A synergistic approach combining exercise with targeted NAD⁺ support, together with emerging strategies involving precursor transporters, trigonelline and hypothalamic NAD⁺–sirtuin circuits, represents a testable avenue that requires rigorous, stratified clinical evaluation.

Читать у издателя →

Похожие статьи